Cardiomyopathies. By G. E. W. Wolstenholme, OBE, MA, MB, FRCP, and Maeve O'Connor, BA. Price, $12.50. Pp 415, Little Brown and Co., Boston, Mass 02106, 1964.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Although well described many years ago, cardiomyopathy is a recently rediscovered disease. It is characterized by massive cardiac hypertrophy and enlargement. In previous years it masqueraded under such diagnoses as coronary artery disease, hypertensive disease, rheumatic heart disease, or myocardial disease of unknown cause.
The clinical picture of cardiomyopathy has a wide spectrum. Although the etiology remains obscure, during the last decade the work of many investigators, particularly Brock and Goodwin in England, Braunwald and Morrow in the United States, and Wigle in Canada, has defined the disease more clearly, recorded its prognosis, and suggested surgical therapy.
The Ciba Foundation Symposium entitled "Cardiomyopathies" is timely because it has brought together a number of investigators whose deliberations are recorded in an orderly fashion in this volume. It is highly recommended to physicians interested in this disease. It will also be useful to clinical pharmacologists because the disease lends itself to study
DAOUD G. Ciba Foundation Symposium. Am J Dis Child. 1965;110(3):341. doi:10.1001/archpedi.1965.02090030355030